Form D — BioGene Therapeutics Inc.
0002140719-26-000001 · filed Jul 23, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,550,000
- Total sold
- $4,550,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BioGene Therapeutics Inc.
- CIK
- 2140719
- Entity
- Corporation
- Jurisdiction
- TEXAS
- Year incorporated
- 2024
- Address
- 5900 BALCONES DR, STE 100
AUSTIN, TX 78731 - Phone
- 1-512-379-7526
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
STEPHEN VAN DEVENTER · Executive OfficerAUSTIN, TX Find on LinkedIn ↗
-
DEEPAK SAMPATH · DirectorAUSTIN, TX Find on LinkedIn ↗
-
PATROSKI LAWSON · DirectorAUSTIN, TX Find on LinkedIn ↗
-
STEVE GLOVER · DirectorAUSTIN, TX Find on LinkedIn ↗
-
RAJ PRUTHI · DirectorAUSTIN, TX Find on LinkedIn ↗
-
DAVID TYRONNE HOWTON · DirectorAUSTIN, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗